Bulk Pharmaceutical API Sources for FLOVENT

Bulk Pharmaceutical API Sources for FLOVENT

Vendor	Vendor Homepage	Vendor Sku	API Url
Molport		MolPort-003-847-468
Hangzhou APIChem Technology		AC-457
Amadis Chemical		A839922
AKos Consulting & Solutions		AKOS015895220
Finetech Industry Limited		FT-0626494
Key Organics/BIONET		KS-1173

Bulk Active Pharmaceutical Ingredient (API) Sources for: FLOVENT

Last updated: July 29, 2025

---

Introduction

Flovent, a well-known inhaled corticosteroid used primarily for asthma management, relies on a precise formulation of its active pharmaceutical ingredient (API), fluticasone propionate. Ensuring a reliable and quality supply of bulk API is crucial for manufacturers aiming to meet global regulatory standards, reduce costs, and maintain consistent product efficacy. This report assesses the primary sources of bulk API for Flovent, examining manufacturer profiles, sourcing strategies, and regulatory considerations.

---

Understanding Fluticasone Propionate as the API for Flovent

Fluticasone propionate, the API in Flovent, is a synthetic corticosteroid with anti-inflammatory properties. Its manufacturing involves complex synthetic pathways that require high purity and stringent quality controls. The API’s quality directly influences the safety and efficacy of the inhaler product, making supplier credibility critical.

---

Leading Bulk API Manufacturers for Fluticasone Propionate

1. GlaxoSmithKline (GSK)

As the original developer of Flutvent (marketed as Flovent in the U.S.), GSK historically managed the API supply chain closely. While GSK has in-house capacity for API production, they also source from select qualified vendors, especially those that meet their rigorous regulatory and quality standards.

• Strengths: Direct involvement ensures robust quality control, integration in R&D, and assured supply.
• Limitations: Limited transparency on external sourcing due to proprietary interests.

2. Teva Pharmaceutical Industries

Teva, a global leader in generics and respiratory medicines, sources fluticasone propionate from multiple reputable API manufacturers. They possess advanced manufacturing facilities with established regulatory approvals, including FDA and EMA inspections.

• Strengths: Extensive API sourcing network, reliable supply chain, and compliance with international standards.
• Regulatory Status: Several manufacturing plants hold approvals from SEMC (Saudi Export Development), EMA, and FDA.

3. Mylan (now part of Viatris)

Mylan's integration into Viatris enhanced their global API sourcing capabilities, including APIs for inhaled corticosteroids like fluticasone propionate.

• API Sources: Collaborates with multiple third-party manufacturers, including facilities in India and China that comply with cGMP standards.
• Supply Chain: Robust procurement strategies mitigate risks of shortages.

4. Cipla

Indian pharmaceutical firm Cipla produces both finished dosage forms and bulk APIs, including fluticasone propionate, supplied mainly to Asian and emerging markets.

• Quality Standards: Adheres to WHO-GMP standards, with some facilities approved by the US FDA.
• Market Focus: Cost-effective API production for regional markets, with increasing capacity to supply globally.

5. Aurobindo Pharma

Aurobindo is a significant API manufacturer with a growing portfolio of respiratory API production, including fluticasone propionate.

• Strengths: Competitive pricing, high quality, and global registrations.
• Regulatory Approvals: Facilities approved by major agencies such as US FDA, EMA, and TGA.

6. Dr. Reddy's Laboratories

Dr. Reddy’s produces API for inhaled corticosteroids, including fluticasone propionate, primarily for markets in Asia, Latin America, and North America.

• Regulatory compliance: Certified by US FDA and other regulatory bodies.

---

Regional & Global API Sourcing Considerations

India and China

India and China are dominant in the global API manufacturing landscape, accounting for approximately 60-80% of the global API supply, including corticosteroids like fluticasone propionate.

• Advantages: Cost-effective production, substantial manufacturing capacity.
• Risks: Regulatory variability, quality concerns, potential supply chain disruptions.

European and North American Manufacturers

Manufacturers in Europe and North America often offer higher assurance levels regarding quality, compliance, and intellectual property protection.

• Advantages: Strict regulatory oversight, advanced quality management.
• Limitations: Higher production costs which may reflect in API pricing.

---

Regulatory and Quality Considerations

API sourcing for Fluticasone propionate must ensure compliance with stringent Good Manufacturing Practice (GMP) standards. Regulatory agencies such as the FDA, EMA, TGA, and PMDA verify API quality at manufacturing sites through inspections and batch testing.

• Documentation: Certificates of Suitability (CEP), Drug Master Files (DMF), and API Certificates of Analysis (CoA) are crucial for regulatory submissions.
• Quality Attributes: Purity (>99%), low residual solvents, absence of nitrosamines, and consistent potency.

---

Emerging Trends in API Sourcing

• Diversification: To mitigate supply chain disruptions, companies diversify API sources across multiple regions.
• Vertical Integration: Some pharmaceutical companies are investing in internal API manufacturing to control quality and supply.
• Suppliers’ Qualification: Emphasis on Qualified Person (QP) approved suppliers with transparent quality management systems.
• Sustainability and Environmental Impact: Increasing focus on environmentally sustainable manufacturing practices.

---

Conclusion

The primary bulk API sources for fluticasone propionate used in Flovent stem from established manufacturers across India, China, Europe, and North America, with India and China leading due to cost advantages. Key players like Mylan, Cipla, Aurobindo, and Teva ensure high-quality API supply, backed by extensive regulatory compliance. However, supply chain stability, regulatory adherence, and quality assurance remain vital factors when selecting an API source.

---

Key Takeaways

• Secure API sourcing from manufacturers with verified GMP compliance and robust regulatory approval, especially for global supply chains.
• Diversify API suppliers to mitigate risks related to geopolitical issues, regulatory changes, or supply disruptions.
• Maintain rigorous quality controls, including verification of Certificates of Analysis and compliance with international quality standards.
• Consider vertical integration or strategic partnerships to ensure supply chain stability.
• Monitor emerging trends such as sustainability practices and technological advancements in API synthesis for future sourcing strategies.

---

FAQs

1. What are the primary regions manufacturing bulk API for Fluticasone Propionate?
India and China dominate API manufacturing due to cost advantages, while Europe and North America focus on quality and regulatory compliance.

2. How do regulatory agencies influence API sourcing decisions?
Regulatory agencies require manufacturers to adhere to cGMP standards, inspect API factories, and approve manufacturing sites via certifications like CEPs and DMFs, crucial for quality assurance.

3. What are the risks associated with sourcing APIs from emerging markets?
Potential risks include variability in quality standards, regulatory discrepancies, intellectual property concerns, and supply chain disruptions.

4. How can pharmaceutical companies ensure API quality?
By conducting supplier audits, verifying Certificates of Analysis, ensuring compliance with international standards, and establishing strong supplier qualification processes.

5. Are there trends toward domestic API manufacturing for Fluticasone Propionate?
Yes, some companies pursue vertical integration or local manufacturing to improve supply security and meet regional regulatory requirements, especially amid global supply chain challenges.

---

References

1. [1] GSK Official Documentation.
2. [2] Teva Pharmaceuticals regulatory filings.
3. [3] Mylan (Viatris) API sourcing profiles.
4. [4] Cipla API manufacturing capabilities.
5. [5] Aurobindo Pharma API Quality Standards.